CFO Thought Leader
JULY 30, 2023
Thus it was for Erin Colgan, who in July 2020—after having invested 9 years within the finance rank-and-file of pharma giant Vertex Pharmaceuticals and 8 years with PWC—opted to become the 20th employee of a promising biotech start-up. Colgan observes: “You can’t make those types of decisions ‘later.’
CFO Thought Leader
MARCH 17, 2024
In the world of finance, where leadership roles await those who distinguish themselves along a select number of familiar paths, Aaron Alt’s journey to becoming a CFO stands out for its breadth and depth, transcending conventional boundaries. We’re a distributor of pharmaceutical products across the U.S.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Future CFO
JANUARY 17, 2022
Hong Kong-listed clinical stage biopharmaceutical firm Transcenta Holding Limited announces the appointment of Daniel Weng as the company's CFO. Prior to Transcenta, he served as the vice president and Head of finance at Hong Kong-listed CStone Pharmaceuticals.
CFO Thought Leader
OCTOBER 29, 2023
Now Read the article on Forbes.com CFO Natalie Laackman discusses the importance of empowering and enabling operational teams to identify ways to add value to clients, especially in the face of escalating costs, and how this approach helps in building client relationships. Like many companies, we’re still early-stage.
The Finance Weekly
APRIL 1, 2023
However, amidst this uncertainty, the need for qualified CFOs remains as crucial as ever. CFO Pros on the Move March 2023 Steve Nave | Funko Funko, the pop-culture toy company, has named , Steve Nave as its CFO and COO. Burke takes over from Brian Cooper, who assumed the CFO role in 2021. She is also a U.S. Army veteran.
Future CFO
NOVEMBER 22, 2022
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced recently the appointment of Mark Lo Chun Bun as CFO of the Group. More CFO appointment news The post Hong Kong-based Immuno Cure BioTech names new CFO appeared first on FutureCFO.
CFO Thought Leader
AUGUST 6, 2023
Still, Ahuja’s Swiss experiences would prove to grow even more valuable in the years ahead, as he would come to occupy the CFO offices of Novartis Korea (3 years) and Novartis Japan (2 years). ” –Dev Ahuja, CFO, Novelis CFOTL: Tell us about Novelis …. In the pharmaceutical space, I was very proud of what I was doing.
Expert insights. Personalized for you.
52 
Let's personalize your content